| Gunnar Gundersen, MD | |
|
111 E Wisconsin Ave, Milwaukee, WI 53202-4815 | |
| (414) 290-6720 | |
| (414) 290-6755 |
| Full Name | Gunnar Gundersen |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 111 E Wisconsin Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356389100 | NPI | - | NPPES |
| 110136768 | Other | WI | MEDICARE RAILROAD |
| 30631600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 24930-020 (Wisconsin) | Primary |
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Parents, teachers, and healthcare providers are among those most concerned by an alarming increase in self-injurious behaviors among young people. Indeed, it has been estimated that the trend has doubled in the past three years and continues to climb as the seemingly bizarre behavior reaches into the middle schools. Despite this emerging epidemic, effective treatment for this challenging anomaly remains elusive.
CEL-SCI Corporation announced today it has received governmental approval from the Health Authority, Ministry of Health of Ukraine, to begin enrollment of subjects for a Phase III clinical trial of Multikine® in Ukraine. Multikine is the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. Ukraine is one of nine countries to participate in this global Phase III trial. The Phase III trial will be run at about 48 clinical centers, of which about 6 centers will be in Ukraine.
The World Psychiatric Association (WPA) is today launching the first ever 'World Mind Matters Day', a global campaign with the main goal of achieving fairness in mental healthcare for all.
News outlets report on both the progress and difficulties states are facing as they attempt to establish health exchanges and meet other health law requirements. Meanwhile, Vermont is hoping to move beyond the federal law as it tries to set up a single payer system.
LifeCodexx AG today reports the successful outcome of a proof-of-principle of its novel assay for non-invasive prenatal testing (NIPT assay) based on quantitative real-time PCR (qPCR). This NIPT assay, designed to determine fetal aneuploidies from maternal blood, will offer significant advantages, such as enhanced test performance at affordable prices, over other prenatal examination methods.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gunnar Gundersen, MD 111 E Wisconsin Ave, Milwaukee, WI 53202-4815 Ph: (414) 290-6720 | Gunnar Gundersen, MD 111 E Wisconsin Ave, Milwaukee, WI 53202-4815 Ph: (414) 290-6720 |
News Archive
Parents, teachers, and healthcare providers are among those most concerned by an alarming increase in self-injurious behaviors among young people. Indeed, it has been estimated that the trend has doubled in the past three years and continues to climb as the seemingly bizarre behavior reaches into the middle schools. Despite this emerging epidemic, effective treatment for this challenging anomaly remains elusive.
CEL-SCI Corporation announced today it has received governmental approval from the Health Authority, Ministry of Health of Ukraine, to begin enrollment of subjects for a Phase III clinical trial of Multikine® in Ukraine. Multikine is the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. Ukraine is one of nine countries to participate in this global Phase III trial. The Phase III trial will be run at about 48 clinical centers, of which about 6 centers will be in Ukraine.
The World Psychiatric Association (WPA) is today launching the first ever 'World Mind Matters Day', a global campaign with the main goal of achieving fairness in mental healthcare for all.
News outlets report on both the progress and difficulties states are facing as they attempt to establish health exchanges and meet other health law requirements. Meanwhile, Vermont is hoping to move beyond the federal law as it tries to set up a single payer system.
LifeCodexx AG today reports the successful outcome of a proof-of-principle of its novel assay for non-invasive prenatal testing (NIPT assay) based on quantitative real-time PCR (qPCR). This NIPT assay, designed to determine fetal aneuploidies from maternal blood, will offer significant advantages, such as enhanced test performance at affordable prices, over other prenatal examination methods.
› Verified 6 days ago
Dr. Colleen Ann Crowe, M.D., M.P.H. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6469 | |
Natalia Rumas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2323 N Lake Dr, Milwaukee, WI 53211 Phone: 414-290-6720 Fax: 414-290-6755 | |
Adam C Ankrum, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 E Wisconsin Ave, Suite 2000, Milwaukee, WI 53202 Phone: 414-290-6720 Fax: 414-290-6755 | |
Andrea Michelle Kraus, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3237 S 16th St Ste 100, Milwaukee, WI 53215 Phone: 414-647-5203 Fax: 414-858-2236 | |
Lisa Hubbard, CFNP Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5000 W Chambers St, Milwaukee, WI 53210 Phone: 414-447-2000 Fax: 414-874-4393 | |
Mr. Brad A. Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Mckenna Jean Knych, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6450 Fax: 414-805-6464 |